New Frontier Possibility for Preventing Ovarian Cancer

New Frontier Possibility for Preventing Ovarian Cancer

Cancer-News

4 weeks
10 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Curtis McCloskey, PhD of @ottawahospital provides insight on a possible new frontier for preventing ovarian cancer.

____________

A laboratory study published in Clinical Cancer Research provides a new perspective on how ovarian cancer is developed and suggests how it can be avoided.

The research is the first to demonstrate that with age occurs the normal ovarian stiffening called fibrosis. It also indicates that this cycle may be prevented by the diabetes medication metformin.

"Fibrosis happens when body tissues are repeatedly injured and inflamed, leaving behind hard collagen fibers that pile up over time, like a scar on the skin," said Dr. Curtis McCloskey, the lead author, "Cancer cells tend to like growing in these fibrotic tissues.

Dr. McCloskey performed the research while he was a PhD student in Dr. Barbara Vanderhyden's lab at The Ottawa Hospital and the University of Ottawa. He is now a postdoctoral fellow at the Princess Margaret Cancer Centre.

Ovarian cancer is the fifth most common cancer in women, with a 5-year survival rate of 45 percent among the worst. People with a family history of ovarian cancer or a BRCA gene mutation are the most susceptible. There is no accurate early cancer screening study. Birth control pills that reduce the risk of ovarian cancer by half or remove ovaries and fallopian pipes are the only options for prevention.

The team found that ovarian fibrosis is a common part of aging, usually after menopause. Dr. McCloskey was shocked during his research to find an ovary by a 69-year-old woman without fibrosis. Medical records revealed that she took metformin, a type 2 diabetes drug. A Taiwanese study previously showed an 82% decrease in ovarian cancer levels in patients with metformin Type 2 diabetes.

The group conducted a series of trials to explore the relations between ovarian fibrosis, aging and metformin.

Read here: https://www.oncologytube.com/video/-wild-idea-opens-possible-new-boundaries-to-ovarian-cancer-prevention

Up Next Autoplay
Phase I/II Study of Ruxolitinib @SeattleCCA @heidigraydrezn5 @UWashOBGYN
Phase I/II Study of Ruxolitinib @SeattleCCA @heidigraydrezn5 @UWashOBGYN
Category: Ovarian Cancer
23 Views
SeattleCCA 6 days
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
13 Views
Cancer-News 4 weeks
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
9 Views
Cancer-News 4 weeks
Study Finds IUD Use Decreased Risk Of Ovarian Cancer By As Much As 32 Percent
Study Finds IUD Use Decreased Risk Of Ovarian Cancer By As Much As 32 Percent
Category: Ovarian Cancer
9 Views
Cancer-News 1 month
PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management
PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management
Category: Ovarian Cancer
123 Views
imedex 7 months
Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy
Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy
Category: Ovarian Cancer
409 Views
imedex 8 months
The importance of encouraging patients to talk about symptoms
The importance of encouraging patients to talk about symptoms
Category: Ovarian Cancer
101 Views
VJOncology 1 year
Quality of life can impact PFS in ovarian cancer
Quality of life can impact PFS in ovarian cancer
Category: Ovarian Cancer
79 Views
VJOncology 1 year
Management of immunotherapy toxicity in gynecological cancers
Management of immunotherapy toxicity in gynecological cancers
Category: Ovarian Cancer
523 Views
VJOncology 1 year